Table 2.
Patient cohort Elixhauser comorbidities.
| No CHIP N = 3,0101 | CHIP N = 2201 | Age-Adjusted P2 | |
|---|---|---|---|
| Comorbidities | |||
| Congestive Heart Failure | 842 (28%) | 72 (33%) | 0.69 |
| Arrhythmia | 2,302 (77%) | 182 (83%) | 0.25 |
| Valvular Disease | 631 (21%) | 48 (22%) | 0.42 |
| Pulm. Circulatory Disorders | 505 (17%) | 31 (14%) | 0.39 |
| Peripheral Vascular Disease | 486 (16%) | 59 (27%) | 0.1 |
| Uncomplicated Hypertension | 1,571 (52%) | 122 (55%) | 0.13 |
| Complicated Hypertension | 458 (15%) | 37 (17%) | 0.66 |
| Paralysis | 174 (5.8%) | 10 (4.5%) | 0.83 |
| Other Neurological Disorders | 688 (23%) | 56 (25%) | 0.47 |
| Chronic Pulm. Disease | 947 (31%) | 82 (37%) | 0.71 |
| Uncomplicated Diabetes | 720 (24%) | 73 (33%) | 0.09 |
| Complicated Diabetes | 437 (15%) | 25 (11%) | 0.05 |
| Hypothyroidism | 472 (16%) | 39 (18%) | 0.5 |
| Renal Failure | 812 (27%) | 65 (30%) | 0.82 |
| Liver Disease | 753 (25%) | 64 (29%) | 0.06 |
| Peptic Ulcer Disease | 63 (2.1%) | 9 (4.1%) | 0.05 |
| AIDS/HIV | 52 (1.7%) | 2 (0.9%) | 0.82 |
| Lymphoma | 78 (2.6%) | 4 (1.8%) | 0.35 |
| Metastatic Cancer | 309 (10%) | 15 (6.8%) | 0.07 |
| Solid Tumor | 934 (31%) | 85 (39%) | 0.37 |
| Rheumatoid Arthritis | 197 (6.6%) | 15 (6.8%) | 0.95 |
| Coagulopathy | 1,077 (36%) | 83 (38%) | 0.61 |
| Obesity | 513 (17%) | 24 (11%) | 0.06 |
| Weight Loss | 1,034 (34%) | 84 (38%) | 0.48 |
| Fluid/Electrolyte Disorder | 2,417 (80%) | 179 (81%) | 0.88 |
| Blood Loss Anemia | 135 (4.5%) | 13 (5.9%) | 0.13 |
| Deficiency Anemia | 795 (26%) | 60 (27%) | 0.42 |
| Alcohol Abuse | 639 (21%) | 44 (20%) | 0.84 |
| Drug Abuse | 152 (5.1%) | 7 (3.2%) | 0.97 |
| Psychoses | 121 (4.0%) | 10 (4.5%) | 0.29 |
| Depression | 625 (21%) | 44 (20%) | 0.49 |
| Elixhauser Comorbidity Score | 20 (13, 28) | 22 (15, 30) | 0.26 |
| Elixhauser Number of Comorbidities | 7 (5, 9) | 7 (6, 9) | 0.43 |
1
Median (Q1, Q3); n (%)
2
Binary Logistic or Linear regression